AVTR Jul 2024 23.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.3500

0.0000

(0.00%)

As of 11:16AM EDT. Market open.

Loading interactive chart…

Zacks
Avantor (AVTR) Launches Solutions for Gene Therapy Harvest
Avantor's (AVTR) solutions are intended to provide gene therapy manufacturers with sustainable and efficient alternatives to traditional methods, thus improving viral particle harvest and quality
Simply Wall St.
What Is Avantor, Inc.'s (NYSE:AVTR) Share Price Doing?
Avantor, Inc. ( NYSE:AVTR ) received a lot of attention from a substantial price movement on the NYSE over the last few...
PR Newswire
Avantor® Announces New J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced the launch of two innovative products that together sustainably optimize the gene therapy harvest process: J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease.